Top Markets
Coin of the day
MicroPort NeuroTech Limited MicroPort NeuroTech Limited

MicroPort NeuroTech Limited

2172
Rang in aandelen #11874
Established in 2004 and headquartered in Shanghai, People's Republic of China,... Established in 2004 and headquartered in Shanghai, People's Republic of China, MicroPort NeuroTech Limited is dedicated to the research, development, manufacturing, and global commercialization of neuro-interventional medical devices. The company's diverse product portfolio addresses various cerebrovascular conditions. For treating hemorrhagic stroke, it offers the NUMEN coil embolization system, the NUMEN FR coil detachment system, the Tubridge flow-diverting stent, the Willis intracranial stent graft system, and the Rebridge intracranial visualized stent. Additionally, MicroPort NeuroTech supplies the APOLLO intracranial arterial stent system for intracranial atherosclerotic disease, as well as the Bridge rapamycin target eluting vertebral artery stent system specifically designed for cerebral atherosclerotic stenosis. To address acute ischemic stroke, the company provides the Neurohawk stent thrombectomy device and the Tigertriever adjustable stent retriever.
Aandeelprijs
$1.04
Marktkapitalisatie
$603.62M
Verandering (1 dag)
-2.52%
Verandering (1 jaar)
-38.05%
Land
CN
Handel MicroPort NeuroTech Limited (2172)

Categorie

Dividendrendementgeschiedenis voor MicroPort NeuroTech Limited (2172)
Het dividendrendement (TTM) van MicroPort NeuroTech Limited (aandelsymbool: 2172) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van MicroPort NeuroTech Limited (2172) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten